Espicom market intelligence, brought to you by Business Monitor InternationalOVERVIEW OF THE PHARMACEUTICAL MARKET IN THE NETHERLANDSWhile the Netherlands is a low-risk market from the point of view of multinational drugmakers, the country's modest per capita expenditure on pharmaceuticals relative to other Western European countries is an issue. Another challenge facing drugmakers is cost-containment, which will only intensify as the Netherlands enters a period of slower economic growth. In fact, as we warned , the Dutch authorities recently introduced a new scheme - reimbursement for medicines that prove therapeutically ineffective will be reclaimed from the manufacturer - to reduce public healthcare costs. BMI notes that the 'no cure, no pay' scheme implemented by the Dutch government is not a new concept , with t he US government and a number of Western European governments already having made risk - sharing or money-back guarantee agreements with drug companies. However, these agreements focused on particular medicines, unlike the much harsher 'blanket' stance of the Dutch health ministry.Headline Expenditure Projections Pharmaceuticals : EUR6.70bn (US$9.31bn) in 2011 to EUR6.51bn (US$8.27bn) in 2012; -2.8% in local currency terms and -11.2% in US dollar terms. Forecast unchanged from Q4 12. Healthcare : EUR62.94bn (US$87.49bn) in 2011 to EUR64.43bn (US$81.83bn) in 2012; +2.4% in local currency terms and -6.5% in US dollar terms. Forecast unchanged from Q4 12. Medical d evices: EUR11.41bn (US$15.86bn) in 2011 to EUR11.72bn (US$14.89bn) in 2012; +2.8% in local currency terms and -6.1% in US dollar terms. Forecast unchanged from Q4 12. Competitive Landscape The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
The Pharmaceutical Market: Netherlands, Business Monitor
International
Published on January 2013
Report Summary
Espicom market intelligence, brought to you by Business Monitor International
OVERVIEW OF THE PHARMACEUTICAL MARKET IN THE NETHERLANDS
While the Netherlands is a low-risk market from the point of view of multinational drugmakers, the country's modest per capita
expenditure on pharmaceuticals relative to other Western European countries is an issue. Another challenge facing drugmakers is
cost-containment, which will only intensify as the Netherlands enters a period of slower economic growth. In fact, as we warned , the
Dutch authorities recently introduced a new scheme - reimbursement for medicines that prove therapeutically ineffective will be
reclaimed from the manufacturer - to reduce public healthcare costs. BMI notes that the 'no cure, no pay' scheme implemented by the
Dutch government is not a new concept , with t he US government and a number of Western European governments already having
made risk - sharing or money-back guarantee agreements with drug companies. However, these agreements focused on particular
medicines, unlike the much harsher 'blanket' stance of the Dutch health ministry.
Headline Expenditure Projections
Pharmaceuticals : EUR6.70bn (US$9.31bn) in 2011 to EUR6.51bn (US$8.27bn) in 2012; -2.8% in local currency terms and -11.2%
in US dollar terms. Forecast unchanged from Q4 12.
Healthcare : EUR62.94bn (US$87.49bn) in 2011 to EUR64.43bn (US$81.83bn) in 2012; +2.4% in local currency terms and -6.5% in
US dollar terms. Forecast unchanged from Q4 12.
Medical d evices: EUR11.41bn (US$15.86bn) in 2011 to EUR11.72bn (US$14.89bn) in 2012; +2.8% in local currency terms and
-6.1% in US dollar terms. Forecast unchanged from Q4 12.
Competitive Landscape
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales -
for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
Table of Content
Table of Contents
Executive Summary 5
SWOT Analysis 7
Netherlands Pharmaceuticals And Healthcare Industry SWOT 7
Netherlands Political SWOT 8
The Pharmaceutical Market: Netherlands, Business Monitor International (From Slideshare) Page 1/5

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Netherlands Economic SWOT 8
Netherlands Business Environment SWOT 8
Pharmaceutical Risk/Reward Ratings 10
Table: Western Europe Pharmaceuticals Risk/Reward Ratings, Q113 11
Rewards 12
Risks 12
The Netherlands ' Market Summary 14
Regulatory Regime 16
Regulatory Developments 17
Intellectual Property Regime 18
Pricing Regime 18
Reimbursement Regime 20
Recent Pricing And Reimbursement Developments 21
Industry Developments 22
Epidemiology 22
Non-Communicable Diseases 22
Healthcare Sector 23
Healthcare Funding 24
Health Insurance 25
Table: Key Points Of The Dutch Health Insurance Act, January 1 2006 26
Health Insurance Companies 26
Healthcare Insurance Developments 28
Table: Biosimilars Approved In The EU 29
Research And Development Sector 29
Clinical Trials 31
Medical Devices Industry 33
Medical Devices Industry Developments 33
Industry Forecast Scenario 35
Overall Market Forecast 35
Table: Pharmaceutical Sales Indicators, 2008-2016 36
Healthcare Market Forecast 37
Table: Healthcare Expenditure Indicators, 2008-2016 38
Table: Healthcare Governmental Indicators, 2008-2016 39
Table: Healthcare Private Indicators, 2008-2016 39
Key Growth Factors ' Macroeconomic 40
Table: Netherlands ' Economic Activity 41
Prescription Drug Market Forecast 42
Table: Prescription Drug Sales Indicators, 2008-2016 43
Patented Drug Market Forecast 44
Table: Patented Drug Market Indicators, 2008-2016 44
Generic Drug Market Forecast 46
Table: Generic Drug Sales Indicators, 2008-2016 47
OTC Medicine Market Forecast 48
Table: OTC Medicine Sales Indicators, 2008-2016 49
Table: OTC Medicine Sales Indicators By Category, 2008-2010 51
Pharmaceutical Trade Forecast 52
Table: Exports And Imports Indicators, 2008-2016 53
Medical Devices Market Forecast 55
The Pharmaceutical Market: Netherlands, Business Monitor International (From Slideshare) Page 2/5

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Table: Medical Devices Sales Indicators, 2008-2016 55
Other Healthcare Data 57
Table: Number Of Physicians By Type, 2008-2009 57
Key Risks To BMI's Forecast Scenario 57
Competitive Landscape 59
Pharmaceutical Industry 59
Table: Pharmaceutical Production, 1995-2010 (Euros 000s) 59
Company Activities 60
Pharmaceutical Wholesale Sector 62
Pharmaceutical Retail Sector 63
Company Profiles 66
Local Manufacturers 66
DSM 66
Qiagen 68
Pharming Group 70
Multinational Manufacturers 72
Merck & Co 72
Pfizer 74
GlaxoSmithKline 75
Sanofi 77
Novartis 78
Demographic Data 79
NETHERLANDS ' Population By Age Group 80
NETHERLANDS ' Population By Age Group 81
NETHERLANDS ' Key Population Ratios 82
NETHERLANDS ' Rural and Urban Population 82
Glossary 83
BMI Methodology 85
How We Generate Our Pharmaceutical Industry Forecasts 85
Pharmaceuticals Business Environment Ratings 86
Risk/Reward Ratings Methodology 86
Ratings Overview 86
Table: Pharmaceutical Business Environment Indicators 87
Weighting 88
Table: Weighting Of Components 88
Sources 88
The Pharmaceutical Market: Netherlands, Business Monitor International (From Slideshare) Page 3/5

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
The Pharmaceutical Market: Netherlands, Business Monitor International
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 1 397.25 Quantity: _____
Site License--USD 2 794.50 Quantity: _____
Corporate License--USD 8 383.50 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
The Pharmaceutical Market: Netherlands, Business Monitor International (From Slideshare) Page 4/5

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
The Pharmaceutical Market: Netherlands, Business Monitor International (From Slideshare) Page 5/5